Aclaris Therapeutics
Utility Patent Applications
Last updated:
List of all Aclaris Therapeutics patents 10 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: SUBSTITUTED SULFONAMIDE PYRROLOPYRIDINES AS JAK INHIBITORS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: PEROXIDE FORMULATIONS AND METHODS AND APPLICATORS FOR USING THE SAME Filling date: 6 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: PYRROLOPYRIMIDINE ITK INHIBITORS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: PYRROLOPYRIMIDINE ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Showing 1 to 10 of 10 patents.